Key result
The host factor ANP32A acts at two stages in the influenza A virus replication cycle, supporting viral RNA polymerase activity and avian polymerase function in mammalian hosts.
Why the study?
Understanding how the host factor ANP32A supports avian influenza A virus RNA polymerase activity in mammalian hosts is important for understanding viral replication and developing antiviral strategies.
May guide host-targeted antivirals for influenza; leaves open clinical translation of ANP32A inhibition.
Zoonotic avian influenza A viruses pose a constant threat to global health, and they have the potential to cause pandemics. Species variations in host factor ANP32A play a key role in supporting the activity of avian influenza A virus RNA polymerases in mammalian hosts. Here we show that ANP32A acts at two stages in the influenza A virus replication cycle, supporting recent structural experiments, in line with its essential role. Understanding how ANP32A supports viral RNA polymerase activity and how it supports avian polymerase function in mammalian hosts is important for understanding influenza A virus replication and the development of antiviral strategies against influenza A viruses.
No takes yet. Share an insight, caveat, or question.
Nilsson-Payant et al. (2021) studied Influenza A virus infection. ANP32A was evaluated. The host factor ANP32A acts at two stages in the influenza A virus replication cycle, supporting viral RNA polymerase activity and avian polymerase function in mammalian hosts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: